Establishment and characterization of a cisplatin-resistant cell line, KB-R, derived from oral carcinoma cell line, KB

被引:0
|
作者
Negoro, Kenji
Yamano, Yukio
Fushimi, Kazuaki
Saito, Kengo
Nakatani, Ken
Shiiba, Masashi
Yokoe, Hidetaka
Bukawa, Hiroki
Uzawa, Katsuhiro
Wada, Takeshi
Tanzawa, Hideki
Fujita, Shigeyuki
机构
[1] Chiba Univ, Dept Biol Mol, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan
[2] Chiba Univ, Ctr Excellence Program 21st Century, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan
[3] Wakayama Med Univ, Sch Med, Dept Oral & Maxillofacial Surg, Wakayama, Japan
[4] Chiba Univ Hosp, Div Oral & Maxillofcial Surg, Chiba, Japan
关键词
cisplatin; drug resistance; MTT assay; microarray; pathway analysis; COMBINATION CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; COLORIMETRIC ASSAY; CANCER-PATIENTS; OVARIAN-CANCER; LUNG-CANCER; HEAD; NECK; GENE; CHEMOSENSITIVITY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To investigate the mechanism of the resistance to cisplatin (CDDP), we established the CDDP-resistant cell line, KB-R, from CDDP-sensitive oral carcinoma cell line, KB. The 3-(3, 4-dimethyl-thiazol-2-yl) 2, 5-diphenyltetrazolium bromide (MTT) assay indicated that KB-R is 5.5-fold more resistant to CDDP than KB. Microarray analysis indicated that the expression levels of 1,718 genes were elevated at least fivefold or more in KB-R, compared with KB. The expression status of ATP binding cassette (ABC) transporter genes, which belong to multi-drug resistance genes, was confirmed by semi-quantitative reverse transcriptase-polymerase chain reaction and real-time PCR. MRP1 and MRP2 were up-regulated, whereas MDR1 was down-regulated. Pathway and ontology analysis using the Ingenuity Pathway Analysis tool indicated three highly significant genetic networks including 105 of the 1,718 overexpressed genes and one network including 35 'cell-to-cell signaling and interaction' related genes. Our results suggested that these cell lines, KB and KB-R, may be useful for searching the candidate genes responsible for CDDP-resistance and for further study to understand the mechanism of CDDP-resistance.
引用
收藏
页码:1325 / 1332
页数:8
相关论文
共 50 条
  • [21] Establishment and Characterization of an Oral Mucosal Melanoma Cell Line (MEMO) Derived From a Longstanding Primary Oral Melanoma
    Lourenco, Silvia V.
    Bologna, Sheyla B.
    Hsieh, Ricardo
    Sangueza, Martin
    Fernandes, Juliana D.
    Nico, Marcello M. S.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2013, 35 (02) : 248 - 251
  • [22] Establishment and characterization of an oral melanoma cell line (ME)
    Chang, KW
    Lin, SC
    Chao, SY
    Kwan, PC
    Chiu, CP
    Wong, YK
    ORAL ONCOLOGY, 2001, 37 (03) : 301 - 307
  • [23] Synergistic antitumor effect of ginsenoside Rg3 and cisplatin in cisplatin-resistant bladder tumor cell line
    Lee, Young Ju
    Lee, Sangchul
    Ho, Jin Nyoung
    Byun, Seok-Soo
    Hong, Sung Kyu
    Lee, Sang Eun
    Lee, Eunsik
    ONCOLOGY REPORTS, 2014, 32 (05) : 1803 - 1808
  • [24] Cisplatin Plus Cetuximab Inhibits Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Migration and Proliferation but Does Not Enhance Apoptosis
    Choi, Hyeong Sim
    Kim, Young-Kyun
    Yun, Pil-Young
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [25] Enhancement of excision repair of cisplatin-DNA adducts by cell-free extract from a cisplatin-resistant rat cell line
    Hibino, Y
    Hiraoka, Y
    Kamiuchi, S
    Kusashio, E
    Sugano, N
    BIOCHEMICAL PHARMACOLOGY, 1999, 57 (12) : 1415 - 1422
  • [26] Induction of cell death by combination treatment with cisplatin and 5-fluorouracil in a human oral squamous cell carcinoma cell line
    Okamura, Masahiko
    Kobayashi, Masaki
    Suzuki, Fumika
    Shimada, Jun
    Sakagami, Hiroshi
    ANTICANCER RESEARCH, 2007, 27 (5A) : 3331 - 3337
  • [27] Transcriptome profile of OVCAR3 cisplatin-resistant ovarian cancer cell line
    Shruti S Sakhare
    Gautam G Rao
    Sammed N Mandape
    Siddharth Pratap
    BMC Bioinformatics, 15 (Suppl 10)
  • [28] Expression of fascin protein and mRNA in the KB carcinoma cell line following treatment with doxorubicin
    Alaeddini, Mojgan
    Fouladdel, Shamileh
    Etemad-Moghadam, Shahroo
    Azizi, Ebrahim
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2011, 7 (04) : 427 - 432
  • [29] Lectin array and glycogene expression analyses of ovarian cancer cell line A2780 and its cisplatin-resistant derivate cell line A2780-cp
    Zhao, Ran
    Qin, Wenjun
    Qin, Ruihuan
    Han, Jing
    Li, Can
    Wang, Yisheng
    Xu, Congjian
    CLINICAL PROTEOMICS, 2017, 14
  • [30] Lectin array and glycogene expression analyses of ovarian cancer cell line A2780 and its cisplatin-resistant derivate cell line A2780-cp
    Ran Zhao
    Wenjun Qin
    Ruihuan Qin
    Jing Han
    Can Li
    Yisheng Wang
    Congjian Xu
    Clinical Proteomics, 2017, 14